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 Abstract  
 
Background: Biliary atresia (BA), a cholangiopathy of unknown aetiology affecting infants, is 
frequently associated with intrahepatic mononuclear cell infiltrate and an abnormal reaction to viral 
exposure has been hypothesised in some cases. 
AIM: to investigate the nature of the CD4+ hepatic infiltrate in defined clinical variants of BA by 
quantifying the various inflammatory cell components. 
Methods:  Liver biopsies of BA infants obtained at Kasai portoenterostomy (KPE) were stained 
immunohistochemically using monoclonal antibodies to Tbet, GATA-3, FOXP3 and IL-17, identifying 
Th-1, Th-2, Tregs and Th-17 cells respectively.  T cells were counted using a graticule technique. Data 
are reported as median (range) of cells per high-power-field (x400) and compared using non-
parametric statistical tests with P≤0.05 regarded as significant. 
Main Results:  Liver biopsies from BA (n=37) and age-matched cholestatic controls (n=12) were 
used. BA infants were divided into three groups: cytomegalovirus IgM+ve (CMV; n=9); BA splenic 
malformation (BASM; n=9) and isolated BA (IBA; n=19). All T-cell subsets were present in the portal 
tracts, with an overrepresentation of Th-1 (P<0.001) and Th-17 (P<0.03), but not Th-2 (P=0.94) or 
Tregs (P=0.15), compared to controls. Th-1 cells predominated in the CMV group; [18 (7-37) vs. 3 (0 
– 14) (BASM) and vs. 5 (3 – 23) (IBA); P<0.01 both], while no sub-group differences were seen for 
Th17 cells.  The degree of Th-1 cell infiltrate inversely correlated with platelet count (rS=-
0.49;P<0.01).  
Th17 cells were fewer [6(2–11) vs. 11(8-20); P=0.02] in infants who cleared their jaundice (n=15,<20 
μmol/L) although this did not translate to improved native liver survival (P=0.17).  
Conclusion: Th-17 cells infiltrate the liver in BA and are associated with a worse surgical outcome; a 
Th-1 profile predominates in CMV-associated BA.   
 
 
  
Hill et al. 2014 
 
5 
 
Introduction 
Biliary Atresia (BA) is an occlusive pan-ductular cholangiopathy presenting in neonatal life with an 
incidence in Europe ranging from 1 in 17-20,000 (1,2). Characteristically, there is cholestasis with a 
progressive inflammatory infiltrate in most (but not all) cases and an early-onset of liver fibrosis 
leading ultimately to cirrhosis and end-stage liver failure within six months if untreated (3).  
 
A single uniform pathogenic mechanism appears unlikely since there is much clinical evidence for 
aetiological heterogeneity with BA being simply the final common phenotype. There are infants with 
clear evidence of a developmental defect, either because the BA is one of a range of disparate 
anomalies such as situs inversus, polysplenia and venous anomalies [i.e. Biliary Atresia Splenic 
Malformation syndrome (BASM) (5), or because the bile duct abnormality has structural changes 
making it detectable from the 16th week of gestation (i.e. cystic biliary stresia) (6). More common are 
other infants, labelled as Isolated BA, who still may have primary developmental bile duct failure, 
but for which there is no clinical evidence. Alternatively, infants may have normal bile ducts at birth, 
which are then damaged secondarily, perhaps by perinatal viral infection or immune-mediated 
injury (7).   
 
A purported relationship to viral infection has been suggested for at least 30 years although 
substantive clinical evidence has been lacking. A wide range of enteric viruses has been implicated 
including REOvirus and cytomegalovirus (CMV) but clinical evidence of exposure and its relevance is 
conflicting whether derived from serological studies (7,8,9) or more directly from PCR studies on 
liver biopsies to detect viral nucleic acids (10).  
 
One of the characteristics of the liver in BA is abnormal over-expression of Class II HLA and 
inflammatory adhesion molecules (e.g. ICAM, VCAM, e-selectin) on bile duct and vascular epithelium 
in isolated BA together with a marked inflammatory lymphocytic infiltrate (11,12). Our initial 
immunohistochemical studies showed this to be predominantly CD4+ T cells and CD56+ NK cells with 
evidence of activation (CD25) and proliferation (CD71)(13). Later studies characterized this as a Th1 
cell mediated portal tract inflammation (through production of IL-2, IFN-γ and TNF-α) (6).  Such Th1 
cell subsets were shown to be oligoclonal suggesting that the T cells in BA proliferate in response to 
a specific antigen, such as viral proteins, or even ‘self’ bile duct epithelial proteins (14).  Later studies 
have concentrated on the alternative effector arm of the immune response involving CD8+ and NK 
cells. Thus, Guo et al. isolated CD8+ T cells and CD56+ NK cells from BA livers and showed marked 
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increases in their activation cytokine profile together with the evidence of cholangiocyte lysis in an 
in-vitro model (15). 
 
Recent advances in CD4+ lymphocyte genealogy has defined two further subsets - regulatory T-cells 
(Tregs) and Th-17 cells (defined by secretion of the cytokine IL-17). The former are known to be 
important in the prevention of autoimmune diseases by maintaining immunological self-tolerance 
and experimental studies in the RRV murine model of BA have shown that lack of Tregs in the first 
three days of life allows an unopposed viral infection to cause bile duct inflammation and occlusion 
(16). Th-17 cells, by contrast, have a destructive role in autoimmune biliary diseases such as primary 
biliary cirrhosis (17) and autoimmune hepatitis (18). 
 
The aim of this study was to investigate the nature of the CD4+ inflammatory infiltrate in BA livers 
with quantification of the various inflammatory cell components and to try and relate this with the 
defined clinical variants. 
 
 
Materials and Methods 
Kings College Hospital is the largest specialist unit for paediatric hepatobiliary disease in the UK and 
a designated referral centre for infants with BA. We identified from a prospectively-maintained 
database four distinct clinical groups according to diagnosis and their age at Kasai portoenterostomy 
(KPE). These included infants with histolologically-proven BA who were: (i) CMV IgM+ve at the time 
of diagnosis; (ii) BASM; (iii) isolated BA, < 60 days at time of KPE or (iv) isolated BA >60 days at time 
of KPE. Surgery was performed using a published technique by a single surgeon (MD). All had had 
wedge liver biopsies taken from the right lobe at the end of the operation and stored in a designated 
tissue bank.  
 
Core liver biopsy material was obtained from age-matched infants with proven α-1 antitrypsin 
deficiency and Alagille syndrome for use as neonatal cholestatic controls. 
 
Biopsies were initially fixed in 10% formalin at room temperature for between one and 24 hours 
They were then dehydrated in graded alcohol and xylene solutions before being processed in a 
Tissue-Tek® VIP® 5 Vacuum Infiltration Processor (Sakura Finetek USA, Torrance, CA). Finally they 
were embedded in paraffin wax. Sections were cut at 4µm thickness. 
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Immunohistochemistry. Two different immunohistochemical techniques were used (19, 20) to 
identify Tbet, GATA3, FOX-P3 and IL-17.  
 
The Novocastra™ Novolink™ Polymer Detection System (Leica Microsystems, Newcastle, UK) was 
used to look for the presence of Th1, Th2 and Tregs using antibodies to Tbet, GATA-3 and FOXP3. 
Paraffin sections were deparaffinised in xylene before boiling in a water bath containing Tris-EDTA 
buffer at pH 9 for antigen retrieval. Endogenous peroxidase activity was neutralised with application 
of the Novocastra™ Peroxidase Block (3% hydrogen peroxide). To avoid diffuse, non-specific 
background staining, Novocastra™ Protein Block was then applied. The sections were then incubated 
with mouse monoclonal primary antibody (to Tbet, GATA-3 and FoxP3) for one hour at room 
temperature after which time the Post-Primary block was applied for 30 minutes. Following this the 
slides were incubated with the secondary antibody, Novolink™ polymer (anti-mouse IgG). 
Peroxidase activity was developed using a mixture of DAB substrate solution and produced a visible 
brown precipitate at the antigen site. Biopsies were then washed and counter-stained with 
haematoxylin. 
 
An avidin-biotin immunoperoxidase technique was used to detect Il-17. Paraffin sections were 
deparaffinised in xylene and then re-hydrated in ethanol. The antigens were unmasked by boiling 
the sections in sodium citrate buffer at pH 6. Endogenous peroxidase was neutralised by incubating 
with Novocastra™ peroxidase block (3% hydrogen peroxide). Following this, the biopsies were 
incubated for 10 minutes with 10% horse serum to inhibit non-specific background staining. After 
washing, avidin and then biotin blocking reagents were applied for 15 minutes each. The sections 
were incubated with a polyclonal goat anti-human IL-17 antibody (R&D Systems®, Minneapolis, USA) 
for one hour at room temperature at a 1:30 concentration. The sections were then incubated with 
biotin conjugated secondary antibody (horse anti-goat IgG, diluted 1:50) for 30 minutes. Bound 
antibody was visualised by incubating with Avidin: Biotinylated Peroxidase Complex (Vectastain® 
Elite® ABC Kit, Vector Laboratories Inc, California, USA). Peroxidase activity was then developed 
using  a mixture of DAB substrate solution. The slides were then counter-stained with haematoxylin.  
 
 
Cell Quantification 
Immunostained sections were evaluated using an Olympus BX51® light microscope (Olympus 
Microscopy, Southend-on-Sea, UK). Cell counting was performed according to a previously published 
technique (21, 22) using an ‘eyepiece graticule’ attachment (0.25mm2) to superimpose a cell 
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counting grid (Datasights, Ltd., Middlesex, UK) onto a magnified slide image.  Ten randomly chosen 
portal tracts and ten lobules were counted by two observers (RH, AQ).  This was then expressed as 
the median count / grid [at high power field (hpf) magnification x400].  
 
Clinical details including preoperative liver biochemistry [total bilirubin, aspartate aminotransferase 
(AST), alkaline phosphatase (ALP), γ-glutamyl transferase (GGT) and platelet count] and clinical 
outcome were obtained from the database.  Outcome was defined by clearance of jaundice 
(bilirubin <20 µmol/L) within 6 months of KPE and Kaplan-Meier survival curves constructed to 
illustrate native liver survival.  
 
Institutional and ethical approval was obtained for the study (REC 11/LO/0430). 
 
Data are presented as medians and range, unless otherwise indicated, and intergroup comparison 
evaluated using non-parametric ANOVA (Kruskal-Wallis test) with post-hoc analysis by Mann-
Whitney U test or Wilcoxon matched pairs as appropriate.  Correlation was investigated using the 
Spearman rank correlation coefficient. Survival data were compared using the log-rank test. 
Statistical analyses were performed using GraphPad Prism® (GraphPad Software, Inc. Version 5. La 
Jolla, California, USA). P values <0.05 were considered significant. 
 
 
Results 
Liver biopsies from 49 infants were evaluated and scored (BA, n = 37; alpha-1-antitrypsin, n = 6; 
Alagille syndrome, n = 6). Those with BA had all undergone a KPE between Sept. 2004 and Nov. 2010 
and were divided into (i) CMV IgM+ve (n = 9), (ii) BASM (n = 9), (iii) isolated BA, < 60 days at time of 
KPE (n = 9) and (iv) isolated BA >60 days at time of KPE (n = 10).  For comparative purposes groups 
(iii) and (iv) were usually combined as “isolated BA” (IBA) (n = 19).  
 
Median (range) age at liver biopsy in the control groups was 57 (21-96) days.  Median age at KPE was 
62 (36 - 141) days (group i); 63 (44 – 94) days (group ii); 42 (36 – 47) days (group iii) and 67 (60 – 70) 
days (group iv) in the BA sub-groups.  
 
All T cell subsets were present principally in the portal tracts of infants with BA but in varying 
quantities (Table 1). Broadly, these consisted of Th-1 [7 (0 – 37) cells/hpf] and Th-17 [9 (0 – 105) 
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cells/hpf] with very few Th-2 [0 (0 – 2) cells/hpf] and Tregs [1 (0 – 7) cells/hpf] cells (Figure 1).  There 
was no significant correlation between the two major T cell subsets (rS = -0.33, P = 0.25).  
 
Successful staining of control material was more problematic (except for Th-17 cells) with only small 
numbers in each group. Nevertheless there were significantly more Th-17 and Th-1 cells in BA 
infants than cholestatic controls (e.g. portal tracts: 9 (0 – 105) vs. 1.5 (0 - 5) cells / hpf; P = 0.0002 
and 7 (0 -37) vs. 2 (0 - 11) cells/hpf; P = 0.03 respectively]. 
 
Th-1 Lymphocytes.  
The Th-1 cells (Tbet+) were found in significantly higher concentrations in the portal tracts compared 
to the lobules of the BA livers [7 (0–37) vs. 3 (0–35) cells/hpf; P = 0.001] (Figure 2). There were 
quantitative differences between the three sub-groups (KW test, P = 0.0008). Thus, there were 
significantly more portal tract Th-1 cells in the CMV group than in both IBA [18 (7–37) vs. 5 (3–23) 
cells/hpf; P=0.002] and BASM [3 (0–14) cells/hpf; P=0.002]. There was no significant difference 
between the BASM and IBA groups [3 (0–14) vs. 5 (3–23) cells/hpf; P = 0.08]. (Figure 3a). 
 
Th-2 Lymphocytes.  
There were very few Th-2 (GATA3+) cells seen in any of the biopsies with little difference between 
portal tract and lobule; and no difference between BA and controls (P = 0.94) nor within the BA sub-
groups (P = 0.8).  
 
Regulatory T Lymphocytes.  
Again, there were very few Tregs (FOXP3+) cells in any of the biopsies (Figure 2). These were 
confined to the portal tracts rather than the lobules of BA livers [1 (0 – 7) vs. 0 (0 – 1) cells/hpf; P = 
0.004].  There was no difference between BA and control livers ([1 (0 – 7) vs. 0 (0-1); P = 0.07] nor 
within the BA sub-sets (P = 0.49).   
 
Th-17 Lymphocytes.  
Th-17 cells were heavily concentrated within the portal tracts as compared to the lobule [9 (0 – 105 
vs. 0 (0 – 4) cells/hpf; P<0.0001] (Figure 2). There were no significant quantitative differences 
between the three BA sub-groups (KW test P = 0.52) (Figure 3b).   
 
We found no quantitative difference between the two isolated BA groups differentiated by age at 
KPE (iii and iv) for the two major T cell sub-groups [Th-1 (P = 0.45) and Th-17 (P = 0.31)].   
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Liver biochemistry and haematology.  
There was no correlation between portal tract Th-1 or Th-17 cell counts in BA livers and their pre-
operative bilirubin, AST or γ-GT (Table 2).  There was a modest correlation between the aspartate 
aminotransferease platelet ratio index (APRi) (28) and Th-1 (rS = 0.32, P = 0.05).     
 
Relationship with outcome.  
Overall 15 (41%) infants cleared their jaundice (bilirubin <20 µmol/L) by six months post-KPE. These 
infants had lower portal tract Th-17 counts than those who did not [6 (0 – 15) vs. 11.5 (0 -105) 
cells/hpf; P = 0.008] (Figure  4a).  In contrast, there was no difference in Th-1 counts [7 (2-37) vs. 7 
(0 – 33) cells/hpf, P =0.49] (Figure 4b). 
 
There were 5 deaths in the series and 21 patients had a liver transplant at a median age of 15 (5 – 
30) months leaving 11 who are alive with their native liver. Figure 5 illustrates the native liver 
survival curve of the BA children divided according the degree of Th-17 infiltration. The difference 
did not reach statistical significance (P = 0.17).  
 
 
Discussion   
The heterogeneity and rarity of human BA has limited interpretation of studies aimed at defining the 
nature of the inflammatory response, believed to be a fundamental characteristic of its 
pathogenesis.  Most detailed studies have been based upon a single experimental model, the RRV-
Balb/c mouse model, whose actual relationship to events in humans is arguable.   
 
We have investigated the distribution of the T cell portal tract infiltrate in subgroups of BA likely to 
have different aetiology, selecting infants with consistent clinical features enabling appropriate 
categorization.  This has allowed reasonable numbers of relatively uncommon clinical variants (e.g. 
BASM) to be studied. We have also defined a group of infants likely to have had a viral contribution 
to their pathogenesis by the presence of CMV IgM antibodies. 
 
Our previous immunohistochemical study shows that the predominant cellular immune response in 
the majority (but not all) of infants with BA consists of an activated CD4 and NK cell portal tract 
infiltrate.   The present study shows a Th-1 and Th-17 predominance quantitatively and for the first 
time shows a marked relationship of the former with CMV IgM+ve associated BA.  
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Several hepatotropic viruses have been incriminated at some time in BA with most studies 
concentrating on a single virus.  By contrast, Rauschenfels et al. (23) investigated a panel of viruses 
in German infants, identifying evidence of viral RNA/DNA in liver biopsies in about 45%, with the 
most common being REOvirus followed by CMV. Viral RNA/DNA positivity did not make any 
difference to survival and outcome in a later published follow-up series (24), leading the authors to 
question whether this had any clinical importance.   Most recent clinical studies have concentrated 
on the putative role of CMV rather than REOvirus in BA. The proportion of CMV IgM +ve infants in 
our clinical series is ~ 10% (unpublished observation) and is similar to the German series. These 
infants are older at presentation, have more severe biochemical indices of liver damage (AST, APRi) 
and a different histological appearance of the liver (broadly inflammatory rather than cholestatic) 
(unpublished observation).  Brindley et al. (25) studied liver memory T cell response to CMV proteins 
and found that 56% of BA infants had significant increases in IFN-γ-producing liver T cells when 
exposed to CMV proteins suggesting perinatal CMV infection.  There is, however, a marked 
geographical variation in CMV +ve BA with only about 10% of all BA infants affected in European 
series (23) compared to 30-50% in those recently reported from Brazil (26) and China (27). 
 
We report here that a major component of the inflammatory infiltrate in BA consists of Th-17 (IL-
17+) cells.  The presence of Th-1 and Th-17 cells appears to be independent with little correlation 
between the two subsets. There is also no correlation with conventional biochemical indices of liver 
damage (AST) or bile duct obstruction (bilirubin, γ-GT) and Th-1 or Th-17 tissue lymphocytes, though 
we have found a modest relationship between Th1 counts and a novel surrogate marker of liver 
fibrosis, the APRi (28). Th-17 cells have been linked to chronic inflammation in primary biliary 
cirrhosis (17, 29), which is believed to have an autoimmune pathogenesis, and in chronic viral 
hepatitis. In these conditions, Th-17 cells are reported to concentrate at the interface of inflamed 
portal tracts and damaged interlobular bile ducts.  Th-17 cells secrete a range of proinflammatory 
cytokines such as IL-23, IL-6, IL-8 and IL-1 and chemokines such as CXCL (CXC-chemokine ligand)-1, 
CXCL2, CXCL3 etc.  
 
Previous work on Th-17 cells and human BA has been limited to a single Chinese study (30). In this, 
there appeared to be a fourfold increase in the proportion of peripheral Th-17 cells in infants with 
isolated BA compared with healthy controls (e.g. intestinal atresia) and more Th-17 cells were 
identified in the portal tracts of BA livers than in healthy control.  Furthermore qRT-PCR analysis 
found that there were 5-6 fold differences in the Th-17 specific transcription factor ROR-γt and IL-
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17a in BA compared to healthy controls.   Unlike our own study, no attempt was made to distinguish 
between different underlying causes of BA.   
 
Regulatory T cells (CD4+CD25+FoxP3+) suppress the immune process and have been used for the 
treatment of experimental models of inflammatory/autoimmune disease such as colitis (31) and 
autoimmune hepatitis (32). The absence of Tregs in the early neonatal period has been suggested as 
one mechanism whereby there is an unrestricted immune response directed against targeted 
cholangiocytes (33). This hypothesis has been largely based on evidence from the Balb/c mouse 
model where adoptive transfer and supplementation of the Treg subset abrogated the biliary 
damage and Treg neutralization prolonged the neonatal window of susceptibility to Rhesus 
Rotavirus, possibly by inhibiting CD86 expression on myeloid dendritic cells (34). Tregs have been 
studied also in the human disease: Brindley et al. (25) have reported differences in peripheral 
FOXP3+ numbers and proportion between 21 infants with isolated BA (and specifically those with 
CMV antibodies and controls. Yang et al. (30) recently showed a two-fold increase in FOXP3+ liver 
infiltration in BA, but a decreased proportion among the peripheral blood mononuclear cells 
compared to healthy controls.  Our quantification study however, did not show any difference in 
infiltrating hepatic Treg numbers between pathological or control groups, though demonstrating 
differences would have been difficult because of the paucity of Tregs in all samples.  
 
A role for the Th-2 pathway is more controversial, though recent murine studies have highlighted a 
Th-2 driven inflammatory response (particularly via IL-13) (35) and B-cell autoimmunity (36) with the 
presence of autoantibodies against α-enolase, an enzyme involved in glycolysis and expressed in 
both bile duct epithelia and hepatocytes, in BA. Autoantibodies to α-enolase have been described in 
patients with BA, suggesting a role for humoral autoimmunity perhaps as a secondary response 
targeting bile duct epithelia (36).  In contrast to these results, we could not confirm the presence of 
a Th-2 infiltrate in our clinical series.  
 
An unknown proportion of infants with BA have a true developmental biliary defect. Most obviously 
these are infants with other congenital abnormalities such as BASM, but there are other scenarios, 
such as cystic BA, where a biliary pathology can be detected on the maternal ultrasound during the 
2nd trimester (5). We have previously reported a series of 3 neonates with BASM where the liver at 
the time of birth appeared, and was histologically, entirely normal (37). Thus even in patients with 
BA where we can be almost certain that the bile duct defect had occurred during the 1st trimester (in 
common with the other components of the syndrome), there was no histologically evident liver 
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damage and certainly no fibrosis. It also seems reasonable to infer that in these any inflammatory 
process might be less marked or indeed entirely absent.  Nonetheless, we could not find any 
difference in the nature of the infiltrate, in cell absolute numbers or in the proportions of the two 
major T-cell subsets, Th-1 and Th-17, in our infants with typical BASM features.  This suggests that 
also in BASM there is the same inflammatory process but that its induction and persistence may be 
due to different mechanisms, such as disruption of biliary ductules and perhaps leakage of cytotoxic 
bile acids outside of the lumen. 
  
The key to outcome in BA is clearance of jaundice. Interestingly, we have found a two-fold difference 
in Th-17 counts between patients who failed to achieve a normal bilirubin level post-KPE and those 
who did. However, just as the cause of biliary atresia can be heterogenous, so the response to the 
KPE is also multifactorial and caution should be exerted in the interpretation of a single observation, 
particularly when cellular in nature (13, 38,29).  In our previous immunohistochemical studies we 
reported that a liver infiltrate characterized by lower numbers of macrophages (CD68+) at the time 
of surgery was correlated to better outcomes at one year in 28 children with BA (13). A similar 
observation was made by Kobayashi et al. in their study of 15 infants (40).  Similarly, we showed (38) 
that raised sVCAM levels at the time of KPE were associated with a poorer outcome in a study of 61 
infants and that post-operative elevation of a range of cell adhesion molecules and cytokines such 
(IL-2, interferon-, IL-4, IL-10, TNF and sICAM-1) was associated with an increased need for early 
transplantation (39). 
 
In conclusion, in this selected study of infants with different types of biliary atresia we have shown 
largely similar inflammatory liver infiltrates consisting of two principal T cell subsets, Th-1 and Th-17. 
The observation of a different inflammatory tissue composition, mainly composed of Th1 cells, in 
those children who were CMV-IgM positive provides circumstantial evidence that CMV-associated 
BA may represent a distinct entity.   
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FIGURE LEGENDS 
 
Figure 1:  Quantitation of T cell subsets in biliary atresia (n = 37) (mean +SEM). 
 
Figure 2: Th-1 (upper), Th-17 (middle ), Treg (lower) and Th-2 (lower) infiltration in infants with 
biliary atresia. 
Upper Row  A (x20) B (x40) Th-1 cells scattered throughout portal tracts and liver of XX day 
infant with isolated BA.  
Middle Row  A (x10) B (x20) Th-17 cells heavily concentrated in the portal tracts of a liver 
from XX day old infant with isolated BA.  
Lower Row A (x40)   B (x40).  A Shows very few Treg (FOXP3+) cells in liver from XX day 
infant with isolated BA. B shows very few Th2 cells in a BA patient again at 40x 
magnification.  
 
Figures 3a & b:    
T cell subset quantification [(a) Th1 and (b) Th17] according to perceived aetiology: CMV IgM+ve BA 
(n = 9); BASM (n = 9); isolated BA (n = 19).   
 
 
Figure 4 (a & b):    
Clearance of jaundice and portal tract T cell subset [Th-17 (a) and Th-1 (b)] 
 
 
Figure 5:  
Native liver survival curve - High (≥ 9 / hpf) versus Low (<9 hpf) Th-17 portal tract infiltration. 
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TABLES 
 
Table 1: Quantification of T cell subsets in portal areas of liver  
 
Biliary Atresia Groups 
 N Th-1 
(Tbet) 
Th-2 
(GATA) 
Th-17 
(IL-17) 
Tregs 
(FOXP3) 
CMV IgM+ 9 18 (7 – 37)* 0 (0 – 0) 6.5 (0 – 26) 1 (0 – 3) 
BASM 9 3 (0 - 14) 0 (0 – 0.5) 8 (0 – 105) 0 (0 – 2) 
IBA (all ages) 19 5 (3 – 23) 0 (0 -2) 9 (0 -30) 0 (0 – 7) 
IBA <60 days 9 5 (3 –  23) 0 (0 – 2) 9 (2  – 30) 0 (0 – 1) 
IBA >60 days 10 5 (3 – 16) 0 (0 – 0.5) 10 (0 – 25) 1 (0  – 7) 
Control Groups 
Alpha-1 
Antitrypsin 
6 8, 10 0,3 2 (1 – 5) 0, 1 
Alagille 
syndrome 
6 2, 0,0 0,0,0 1 (0 – 2) 0,0,0 
 
*expressed as median (range) per grid (high power field x400 magnification) 
 
 
 
  
Hill et al. 2014 
 
20 
 
 
Table 2: Correlation of Biochemical indices and Th-1 and Th-17 counts. 
 
 Th-1 
(n = 29) 
P value Th-17 
(n = 37) 
P value 
Bilirubin 0.14 0.23 -0.17 0.16 
AST 0.07 0.36 0.06 0.47 
GGT -0.1 0.29 0.004 0.49 
APRi 0.32 0.05 -0.05 0.36 
 
AST – aspartate aminotransferase 
GGT – γ-glutamyl aminotransferase 
APRi - Aspartate aminotransferease Platelet Ratio index 
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Figure 1:  Quantitation of T cell subsets in biliary atresia (n = 37) (mean +SEM).  
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Figure 2:   
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Legend  
Th-1 (upper), Th-17 (middle ), Treg (lower) and Th-2 (lower) infiltration in infants with biliary atresia. 
 
Upper Row  A (x20) B (x40) Th-1 cells scattered throughout portal tracts principally and  also lobule 
of liver of XX day infant with isolated BA.  
 
Middle Row  A (x10) B (x20) Th-17 cells heavily concentrated in the portal tracts of a liver from XX 
day old infant with isolated BA.  
 
Lower Row A (x40)   B (x40).  A Shows very few Treg (FOXP3+) cells in liver from XX day infant with 
isolated BA. B shows very few Th2 cells in a BA patient again at 40x magnification.  
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FIGURE 3(a) 
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Figures 3a & b:    
T cell subset quantification [(a) Th1 and (b) Th17] according to perceived aetiology: CMV IgM+ve BA 
(n = 9); BASM (n = 9); isolated BA (n = 19).   
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Figure 4(a) 
 
 
4(b) 
 
 
 
 
Figure 4 (a & b):   Clearance of jaundice and portal tract T cell subset [Th17 (a) and Th1 (b)] 
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Figure 5:  
Native liver survival curve - High (≥ 9 / hpf) versus Low (<9 hpf) Th-17 portal tract infiltration. 
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